AMIX
Autonomix Medical, Inc.
Next earnings ≈ Sep 9, 2026 · est. from filing cadence
$5.72
▼ -10.34%$5.72▼ -78.03%
over 1Y
L $0.32EODHDH $42.21
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-10.3%
1W-10.3%
1M-34.7%
3M-32.0%
YTD-49.3%
1Y-78.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.29x).
Autonomix Medical, Inc. shows $0.00 in FY2026 revenue, and -283.5% ROE.
Financials · annual, by fiscal year
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | — | — | — | — |
| Operating income | -$1.99M | -$12.0M | -$11.6M | -$17.0M |
| Net income | -$1.99M | -$15.4M | -$11.4M | -$16.7M |
| Diluted EPS | — | — | — | — |
| Net margin | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$58.3M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-25.6%
FCF yield-18.8%
Quality & risk
ROIC (est.)-228.3%
Free cash flow-$12.3M
Total debt—
Net cash$7.00M
Altman Z-Score4.14 safe
Piotroski F-Score1/7
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+310.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2026-06-15). Worth a closer look.
- 8-K Material event2026-06-24
- 10-K/A Restated periodic report2026-06-15
- 10-K Annual report2026-05-27
- 10-Q Quarterly report2026-02-11
- 8-K Delisting notice2026-01-16
- 8-K Reg FD disclosure2026-01-09
- S-3 Shelf registration (potential raise)2025-11-26
- 8-K Material agreement2025-11-19
- 10-Q Quarterly report2025-11-12
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-182026-06-24open ↗10-K/APeriod ending 2026-03-312026-06-15open ↗10-KPeriod ending 2026-03-312026-05-27open ↗S-8Filing2026-04-02open ↗10-QPeriod ending 2025-12-312026-02-11open ↗8-KPeriod ending 2026-01-142026-01-16open ↗8-KPeriod ending 2026-01-092026-01-09open ↗424B3Filing2025-12-12open ↗EFFECTFiling2025-12-11open ↗CORRESPFiling2025-12-09open ↗S-3Filing2025-11-26open ↗8-KPeriod ending 2025-11-182025-11-19open ↗
Frequently asked
- Is Autonomix Medical, Inc. (AMIX) a buy?
- AMIX currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.29x).
- What is Autonomix Medical, Inc.'s quality score?
- AMIX scores 36.179487179487175/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001617867, latest 10-K filed 2026-05-27) · EODHD · as of 6/22/2026, 11:29:28 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.